Mumbai-based Sun Pharma, signed a licensing agreement with Sun Pharma Advanced Research Company (SPARC) to commercialize the drug benzyl alcohol and propylene glycol-free phenobarbital sodium powder, SEZABY for the treatment of neonatal seizures, in the U.S. market. SPARC submitted a new drug application to the U.S. Food and Drug Administration...